• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

FELIQS

Tuesday, June 04, 2024
Start-Up Stadium Session
Ophthalmology
Company Description: FELIQS is a clinical-ready stage company. The Company has a portfolio of two patent-protected drug product ophthalmology candidates: - Retinopathy of prematurity (ROP) – FLQ-101, a lipid peroxidation inhibitor repurposed to prevent ROP. FLQ-101 will be in Phase I dosing planned in the US in 2024. Successful submission of Orphan Drug Designation to FDA. - Age-related macular degeneration (AMD) – FLQ-104, a proprietary lipid peroxidation and ferroptosis inhibitor for earlier intervention to treat AMD. FLQ-104 is currently in the discovery stage in Japan and in the US. FELIQS identifies each developmental candidate through its proprietary screening platform, specifically targeting lipid peroxidation/ferroptosis. These candidates have demonstrated proven efficacy in past prospective clinical trials. Each developmental candidate offers an attractive value proposition in terms of safety and convenient route of administration (oral). FELIQS is actively advancing its pipelines into clinical development, backed by well-experienced academic and industrial advisors. We're initiating a Series A round targeting $20 million to initiate a clinical trial for ROP(FLQ-101), and preclinical research for FLQ-104. For this expansion of the future product portfolio and to prepare for a successful future M&A or NASDAQ IPO. We look for investors and partners to participate in the opportunity of this new and proprietary technology.

FELIQS
Company Website: https://www.feliqs.com/

Company HQ City

Kurume

Company HQ State

Fukuoka

Company HQ Country

Japan

CEO/Top Company Official

Kenichiro "Nobu"Kuninobu, Ph.D.
Primary Speaker
Kenichiro Kuninobu, PhD
Co-founder and CEO
Feliqs
Back to Session List

white squarewhite

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS